Evidence map›Paper›PMID 41611477›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Juliano J Cerci, Stefano Fanti, Enrique E Lobato, Rakesh Kumar, Jolanta Kunikowska, Akram Al-Ibraheem, Maisarah Nasir, Francisca Redondo Moneda, Osvaldo Garcia, Mohamad Haidar and 5 more

Abstract readClinical StudyMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Juliano J CerciQuanta Diagnostico e Terapia, Curitiba, Brazil; cercijuliano@hotmail.com.
Stefano FantiIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Enrique E LobatoDivision of Human Health, International Atomic Energy Agency, Vienna, Austria.
Rakesh KumarAll India Institute of Medical Sciences, New Delhi, India.
Jolanta KunikowskaNuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland.
Akram Al-IbraheemKing Hussein Cancer Center, Amman, Jordan.
Maisarah NasirInstitute Kanser Negara, Putrajaya, Malaysia.
Francisca Redondo MonedaAsistencial Sotero del Río, Santiago Clínica Andes Salud, Puerto Montt, Chile.
Osvaldo GarciaInstituto Nacional de Cancerologia, Tlalpan, Mexico.
Mohamad HaidarAmerican University of Beirut Medical Center, Beirut, Lebanon.
Fuad NovruzovNuclear Medicine Department, National Centre of Oncology, Baku, Azerbaijan.
Ozlem KucukAnkara University, Ankara, Turkey.
Umut ElbogaUniversity of Gaziantep, Gaziantep, Turkey; and.
Murilo de Almeida LuzIcahn School of Medicine at Mount Sinai, New York, New York.
Diana PaezDivision of Human Health, International Atomic Energy Agency, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although multiple studies have demonstrated the accuracy of

Indexed as

Edetic AcidOligopeptidesPositron Emission Tomography Computed TomographyProstatic NeoplasmsAgedGallium IsotopesGallium RadioisotopesHumansMaleMiddle AgedNeoplasm StagingPrognosisSurvival AnalysisEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesOligopeptidesinitial stagingoncologyPET/CTprognosisprostate cancerPSMA

Identifiers

PMID41611477
PMCPMC13041606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.